► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
German healthcare group Bayer has made a €2bn bid for Norway's Algeta, hoping to gain full control over a potentially lucrative cancer drug. Lex's Nikki Tait and Vincent Boland weigh the companies' next moves.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
German healthcare group Bayer has made a €2bn bid for Norway's Algeta, hoping to gain full control over a potentially lucrative cancer drug. Lex's Nikki Tait and Vincent Boland weigh the companies' next moves.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
Category
🗞
News